Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

TherapeuticsMD, Inc. (TXMD) vs Universe Pharmaceuticals INC (UPC)

TherapeuticsMD, Inc. and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. TherapeuticsMD, Inc. and Universe Pharmaceuticals INC are of similar size ($24.7M and $23.5M). Universe Pharmaceuticals INC has the higher net margin (−6.42% vs −6.64%) and the higher return on invested capital (0.00% vs −13.8%). Across the 15 metrics below, Universe Pharmaceuticals INC leads on 9 and TherapeuticsMD, Inc. on 6.

Valuation

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 7.26 n/m 2.25
P/B 0.87 n/m 1.90
Price to free cash flow 8.72 n/m 16.54
EV/EBITDA n/m 8.52 12.29
EV/Sales 6.95 (0.24) 2.56
Earnings yield (1.14%) (30.74%) (2.99%)
Free cash flow yield 11.47% 0.00% 0.00%

Profitability

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
Gross margin 100.00% 49.77% 53.94%
Operating margin (120.89%) 0.00% 0.00%
Net margin (6.64%) (6.42%) 0.00%
Free cash flow margin 94.71% 0.00% 0.00%
Return on equity (0.80%) 0.00% (0.40%)
Return on assets (0.57%) 0.00% (3.32%)
Return on invested capital (13.77%) 0.00% 0.00%

Growth

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 27.78% — 10.01%
EPS growth (last fiscal year) 73.68% 98.71% —
Revenue growth, 5-year CAGR (45.84%) (10.27%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.17 0.05
Current ratio 3.22 4.05 2.31
Net debt to EBITDA 2.34 10.15 0.85

Dividend

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric TXMD UPC Drug Manufacturers Specialty & Generic median
Market cap 24.65m 23.54m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack